Pharmacological management of behavioural and psychological disturbance in dementia
Tóm tắt
Behavioural and psychological symptoms in patients with dementia are common, distressing and often difficult to manage. This review evaluates a range of drugs commonly used to manage these symptoms including antipsychotics, anticonvulsants, antidementia drugs and antidepressants.
The risks and benefits of individual treatments are discussed and the relatively poor evidence base and need for further research is highlighted. Copyright © 2006 John Wiley & Sons, Ltd.
Từ khóa
Tài liệu tham khảo
Ballard C, 2005, Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: a randomised, double‐blind, placebo‐controlled trial, Br Med J, 330, 874, 10.1136/bmj.38369.459988.8F
Beber CR, 1965, Management of behaviour in the institutionalized aged, Dis Nerv Syst, 26, 591
Cooper J, 2003, Buspirone for anxiety and agitation in dementia, J Psychiatry Neurosci, 28, 496
Curran S, 2004, Practical Management of Dementia—A Multi‐Professional Approach
Food and Drug Administration—US FDA.2005.Off‐label use of atypical antipsychotics linked to increased mortality in the elderly.www.medscape.com
Gill SS, 2005, Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study, Br Med J
Jewart RD, 2005, Cognitive, behavioural and physiological changes in Alzheimer's disease patients as a function of incontinence medications, Am J Psychiatry, 13, 324
Jost BC, 1996, The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study, Am J Geriatr Psychiatry, 4, 383
Kaufer D, 1998, Assessing the effects of donepezil in Alzheimer's patients and its impact on caregivers, J Am Geriatr Soc, 46, 198
Lonergan E, 2002, the Cochrane Library
MonschAU Heiter‐ReiffenstuhlI BraendleD.2002.Galantamine reduces behavioural and psychological disturbances and related caregiver burden in Alzheimer's disease patients. Poster at the 6th Congress of the European Federation of Neurological Societies Vienna.
Oflasson K, 1992, Fluvoxamine in the treatment of the demented elderly patients: a double‐blind placebo‐controlled study, Acta Psychiatrica Scandinavica, 851, 453
Overall JE, 1962, The Brief Psychiatric Rating‐Scale, Psychol Rep, 10, 799, 10.2466/pr0.1962.10.3.799
Reisberg B, 1987, Behavioural symptoms in Alzheimer's disease, phenomenology and treatment, J Clin Psychiatry, 48, 9
Rosler M, 2002, The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia, Int J Clin Psych, 127, 20
SchneiderL YeungP SweitzerD et al.1999.Effects of quetiapine reducing hostility and psychosis in patients with Alzheimer's disease/Poster NR657presented at the 152nd American Psychiatric Association (APA) meeting; 1999 May 15–20; Washington DC.
Tariot P, 1994, Handbook of Dementing Illnesses
Tariot PN, 2002, Quetiapine in nursing home residents with Alzheimer's dementia and psychosis, Am J Geriatr Psychiatry, 10, 93
Verny M, 2004, Reduced psychotropic drug use in patients with Alzheimer's disease receiving rivastigmine: results of the EXELAN study, J Drug Ass, 7, 1